Saudi Arabia Health Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Surveillance and Treatment Of Primary Hepatocellular Carcinoma: A Prospective Observational Cohort Study of High-Risk Patients for HCC Using GALAD-Score
Conditions: Liver Cancer; Liver Cirrhosis; Liver Fibrosis; Hepatocellular Carcinoma Intervention: Diagnostic Test: GALAD Score Sponsors: Johns Hopkins University; King Faisal Specialist Hospital and Research Center in Riyadh (Saudi Arabia); Medic Medical Center (Viet Nam) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2022 Category: Research Source Type: clinical trials
Surveillance and Treatment Of Primary Hepatocellular Carcinoma in Viet Nam and Saudi Arabia: A Prospective Cohort Study of High-Risk Patients for HCC Using Liquid Biopsy
Conditions: Liver Cancer; Liver Cirrhosis; Liver Fibrosis; Hepatocellular Carcinoma Intervention: Diagnostic Test: GALAD Score Sponsors: Johns Hopkins University; King Faisal Specialist Hospital and Research Center in Riyadh (Saudi Arabia); Medic Medical Center (Viet Nam) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2022 Category: Research Source Type: clinical trials
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Saudi Arabia, as Part of Local Clinical Practice
Condition: Diabetes Mellitus, Type 2 Intervention: Drug: Oral semaglutide Sponsor: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2022 Category: Research Source Type: clinical trials
